Publications


Steri V; Ellison TS; Gontarczyk AM; Weilbaecher K; Schneider JG; Edwards D; Fruttiger M; Hodivala-Dilke KM; Robinson SD, 2014. Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice.  Circ Res 114(1):79-91

Kelwick R; Wagstaff L; Decock J; Roghi C; Cooley LS; Robinson SD; Arnold H; Gavrilović J; Jaworski DM; Yamamoto K; Nagase H; Seubert B; Krüger A; Edwards DR, 2014. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15.  Int J Cancer.

Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL, 2014. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.  Clin Cancer Res 20(2):344-57

Thirkettle S; Decock J; Arnold H; Pennington CJ; Jaworski DM; Edwards DR, 2013. Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells.  J Biol Chem 288(23):16282-94

Gerrard DT; Fricke C; Edward DA; Edwards DR; Chapman T, 2013. Genome-Wide Responses of Female Fruit Flies Subjected to Divergent Mating Regimes.  PLoS One 8(6):e68136

Vandooren J; Berghmans N; Dillen C; Van Aelst I; Ronsse I; Israel LL; Rosenberger I; Kreuter J; Lellouche JP; Michaeli S; Locatelli E; Franchini MC; Aiertza MK; Sánchez-Abella L; Loinaz I; Edwards DR; Shenkman L; Opdenakker G, 2013. Intradermal air pouch leukocytosis as an in vivo test for nanoparticles.  Int J Nanomedicine 8:4745-56

Eldred JA; Hodgkinson LM; Dawes LJ; Reddan JR; Edwards DR; Wormstone IM, 2012. MMP2 activity is critical for TGFβ2-induced matrix contraction--implications for fibrosis.  Invest Ophthalmol Vis Sci 53(7):4085-98

Cooley LS; Edwards DR, 2011. New insights into the plasticity of the endothelial phenotype.  Biochem Soc Trans 39(6):1639-43

Decock J; Thirkettle S; Wagstaff L; Edwards DR, 2011. Matrix metalloproteinases: protective roles in cancer.  J Cell Mol Med 15(6):1254-65

Stuchinskaya T; Moreno M; Cook MJ; Edwards DR; Russell DA, 2011. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates.  Photochem Photobiol Sci 10(5):822-31

Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM, 2010. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.  Clin Cancer Res 16(7):2022-35

Bass R; Edwards DR, 2010. ADAMs and protein disulfide isomerase: the key to regulated cell-surface protein ectodomain shedding?  Biochem J 428(3):e3-5

Pennington CJ; Edwards DR, 2010. Real-time PCR expression profiling of MMPs and TIMPs.  Methods Mol Biol 622:159-73

Ravenhill L; Wagstaff L; Edwards DR; Ellis V; Bass R, 2010. G-helix of maspin mediates effects on cell migration and adhesion.  J Biol Chem 285(47):36285-92

Hodgkinson LM; Wang L; Duncan G; Edwards DR; Wormstone IM, 2010. ADAM and ADAMTS gene expression in native and wound healing human lens epithelial cells.  Mol Vis 16:2765-76

Cooley LS; Handsley MM; Zhou Z; Lafleur MA; Pennington CJ; Thompson EW; Pöschl E; Edwards DR, 2010. Reversible transdifferentiation of blood vascular endothelial cells to a lymphatic-like phenotype in vitro.  J Cell Sci 123(Pt 21):3808-16

Sampieri CL; Nuttall RK; Young DA; Goldspink D; Clark IM; Edwards DR, 2008. Activation of p38 and JNK MAPK pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes.  Matrix Biol 27(2):128-38

Clark IM; Swingler TE; Sampieri CL; Edwards DR, 2008. The regulation of matrix metalloproteinases and their inhibitors.  Int J Biochem Cell Biol 40(6-7):1362-78

Shukla CJ; Pennington CJ; Riddick AC; Sethia KK; Ball RY; Edwards DR, 2008. Laser-capture microdissection in prostate cancer research: establishment and validation of a powerful tool for the assessment of tumour-stroma interactions.  BJU Int 101(6):765-74

Edwards DR; Handsley MM; Pennington CJ, 2008. The ADAM metalloproteinases.  Mol Aspects Med 29(5):258-89

Zhong JL; Poghosyan Z; Pennington CJ; Scott X; Handsley MM; Warn A; Gavrilovic J; Honert K; Krüger A; Span PN; Sweep FC; Edwards DR, 2008. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma.  Mol Cancer Res 6(3):383-94

Nuttall RK; Silva C; Hader W; Bar-Or A; Patel KD; Edwards DR; Yong VW, 2007. Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia.  Glia 55(5):516-26

Hodgkinson LM; Duncan G; Wang L; Pennington CJ; Edwards DR; Wormstone IM, 2007. MMP and TIMP expression in quiescent, dividing, and differentiating human lens cells.  Invest Ophthalmol Vis Sci 48(9):4192-9

Porter S; Span PN; Sweep FC; Tjan-Heijnen VC; Pennington CJ; Pedersen TX; Johnsen M; Lund LR; Rømer J; Edwards DR, 2006. ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma.  Int J Cancer 118(5):1241-7

Edwards DP; Hassall M; Sutherland WJ; Yu DW, 2006. Selection for protection in an ant-plant mutualism: host sanctions, host modularity, and the principal-agent game.  Proc Biol Sci 273(1586):595-602

Dalmay T; Edwards DR, 2006. MicroRNAs and the hallmarks of cancer.  Oncogene 25(46):6170-5

Pitchers M; Stokes A; Lonsdale R; Premachandra DJ; Edwards DR, 2006. Research tissue banking in otolaryngology: organization, methods and uses, with reference to practical, ethical and legal issues.  J Laryngol Otol 120(6):433-8

Sarkar S; Nuttall RK; Liu S; Edwards DR; Yong VW, 2006. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12.  Cancer Res 66(24):11771-80

Handsley MM; Edwards DR, 2005. Metalloproteinases and their inhibitors in tumor angiogenesis.  Int J Cancer 115(6):849-60

Porter S; Clark IM; Kevorkian L; Edwards DR, 2005. The ADAMTS metalloproteinases.  Biochem J 386(Pt 1):15-27

Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM, 2005. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.  FEBS J 272(8):1912-26

Young DA; Lakey RL; Pennington CJ; Jones D; Kevorkian L; Edwards DR; Cawston TE; Clark IM, 2005. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption.  Arthritis Res Ther 7(3):R503-12

Singh RJ; Mason JC; Lidington EA; Edwards DR; Nuttall RK; Khokha R; Knauper V; Murphy G; Gavrilovic J, 2005. Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3.  Cardiovasc Res 67(1):39-49

Weaver A; Goncalves da Silva A; Nuttall RK; Edwards DR; Shapiro SD; Rivest S; Yong VW, 2005. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization.  FASEB J 19(12):1668-70

Nuttall RK; Sampieri CL; Pennington CJ; Gill SE; Schultz GA; Edwards DR, 2004. Expression analysis of the entire MMP and TIMP gene families during mouse tissue development.  FEBS Lett 563(1-3):129-34

Kevorkian L; Young DA; Darrah C; Donell ST; Shepstone L; Porter S; Brockbank SM; Edwards DR; Parker AE; Clark IM, 2004. Expression profiling of metalloproteinases and their inhibitors in cartilage.  Arthritis Rheum 50(1):131-41

Porter S; Scott SD; Sassoon EM; Williams MR; Jones JL; Girling AC; Ball RY; Edwards DR, 2004. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma.  Clin Cancer Res 10(7):2429-40

Edwards DR, 2004. TIMP-3 and endocrine therapy of breast cancer: an apoptosis connection emerges.  J Pathol 202(4):391-4

Young DA; Gavrilov S; Pennington CJ; Nuttall RK; Edwards DR; Kitsis RN; Clark IM, 2004. Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes.  Biochem Biophys Res Commun 322(3):759-65

Bevan D; Gherardi E; Fan TP; Edwards D; Warn R, 2004. Diverse and potent activities of HGF/SF in skin wound repair.  J Pathol 203(3):831-8

Nuttall RK; Pennington CJ; Taplin J; Wheal A; Yong VW; Forsyth PA; Edwards DR, 2003. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.  Mol Cancer Res 1(5):333-45

Hall MC; Young DA; Waters JG; Rowan AD; Chantry A; Edwards DR; Clark IM, 2003. The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1.  J Biol Chem 278(12):10304-13

Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V, 2003. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).  Biochem J 372(Pt 3):799-809

Worley JR; Baugh MD; Hughes DA; Edwards DR; Hogan A; Sampson MJ; Gavrilovic J, 2003. Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid.  J Biol Chem 278(51):51340-6

Wells JE; Rice TK; Nuttall RK; Edwards DR; Zekki H; Rivest S; Yong VW, 2003. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice.  J Neurosci 23(31):10107-15

Platt CI; Krekoski CA; Ward RV; Edwards DR; Gavrilovic J, 2003. Extracellular matrix and matrix metalloproteinases in sciatic nerve.  J Neurosci Res 74(3):417-29

Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR, 2002. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.  Matrix Biol 21(1):75-88

Young DA; Phillips BW; Lundy C; Nuttall RK; Hogan A; Schultz GA; Leco KJ; Clark IM; Edwards DR, 2002. Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene.  Biochem J 364(Pt 1):89-99

Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR, 2002. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.  J Biol Chem 277(7):4999-5007

Wall SJ; Edwards DR, 2002. Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRs.  Anal Biochem 300(2):269-73

Wall SJ; Bevan D; Thomas DW; Harding KG; Edwards DR; Murphy G, 2002. Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse.  J Invest Dermatol 119(1):91-8

Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR, 2002. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).  J Cell Sci 115(Pt 17):3427-38

Price JS; Waters JG; Darrah C; Pennington C; Edwards DR; Donell ST; Clark IM, 2002. The role of chondrocyte senescence in osteoarthritis.  Aging Cell 1(1):57-65

Hall MC; Young DA; Rowan AD; Edwards DR; Clark IM, 2002. Cryptic promoter activity of pBLCAT3 induced by overexpression of AP1 factors.  Biotechniques 33(5):1004, 1006, 1008

Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR, 2001. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.  Biochem Biophys Res Commun 282(2):463-73

Wong H; Muzik H; Groft LL; Lafleur MA; Matouk C; Forsyth PA; Schultz GA; Wall SJ; Edwards DR, 2001. Monitoring MMP and TIMP mRNA expression by RT-PCR.  Methods Mol Biol 151:305-20

Lafleur MA; Hollenberg MD; Atkinson SJ; Knäuper V; Murphy G; Edwards DR, 2001. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.  Biochem J 357(Pt 1):107-15

Yeow KM; Phillips BW; Beaudry PP; Leco KJ; Murphy G; Edwards DR, 2001. Expression of MMPs and TIMPs in mammalian cells.  Methods Mol Biol 151:181-9

Maillard M; Cadot B; Ball RY; Sethia K; Edwards DR; Perbal B; Tatoud R, 2001. Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues.  Mol Pathol 54(4):275-80

Groft LL; Muzik H; Rewcastle NB; Johnston RN; Knäuper V; Lafleur MA; Forsyth PA; Edwards DR, 2001. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.  Br J Cancer 85(1):55-63

Yong VW; Power C; Forsyth P; Edwards DR, 2001. Metalloproteinases in biology and pathology of the nervous system.  Nat Rev Neurosci 2(7):502-11

Harvey P; Clark IM; Jaurand MC; Warn RM; Edwards DR, 2000. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases.  Br J Cancer 83(9):1147-53

Dean G; Young DA; Edwards DR; Clark IM, 2000. The human tissue inhibitor of metalloproteinases (TIMP)-1 gene contains repressive elements within the promoter and intron 1.  J Biol Chem 275(42):32664-71

Raithatha SA; Muzik H; Muzik H; Rewcastle NB; Johnston RN; Edwards DR; Forsyth PA, 2000. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas.  Neuro Oncol 2(3):145-50

Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR, 1999. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.  Br J Cancer 79(11-12):1828-35

Frölichsthal-Schoeller P; Vescovi AL; Krekoski CA; Murphy G; Edwards DR; Forsyth P, 1999. Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells.  Neuroreport 10(2):345-51

Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P, 1999. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.  Clin Cancer Res 5(4):845-54

Oh LY; Larsen PH; Krekoski CA; Edwards DR; Donovan F; Werb Z; Yong VW, 1999. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes.  J Neurosci 19(19):8464-75

Kossakowska AE; Edwards DR; Prusinkiewicz C; Zhang MC; Guo D; Urbanski SJ; Grogan T; Marquez LA; Janowska-Wieczorek A, 1999. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.  Blood 94(6):2080-9

Phillips BW; Sharma R; Leco PA; Edwards DR, 1999. A sequence-selective single-strand DNA-binding protein regulates basal transcription of the murine tissue inhibitor of metalloproteinases-1 (Timp-1) gene.  J Biol Chem 274(32):22197-207

Kossakowska AE; Medlicott SA; Edwards DR; Guyn L; Stabbler AL; Sutherland LR; Urbanski SJ, 1999. Elevated plasma gelatinase A (MMP-2) activity is associated with quiescent Crohn's Disease.  Ann N Y Acad Sci 878:578-80

Kossakowska AE; Hinek A; Edwards DR; Lim MS; Zhang CL; Breitman DR; Prusinkiewicz C; Stabbler AL; Urbanski LS; Urbanski SJ, 1998. Proteolytic activity of human non-Hodgkin's lymphomas.  Am J Pathol 152(2):565-76

Yong VW; Krekoski CA; Forsyth PA; Bell R; Edwards DR, 1998. Matrix metalloproteinases and diseases of the CNS.  Trends Neurosci 21(2):75-80

Forsyth PA; Laing TD; Gibson AW; Rewcastle NB; Brasher P; Sutherland G; Johnston RN; Edwards DR, 1998. High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma.  J Neurooncol 36(1):21-9

Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ, 1998. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.  Am J Pathol 153(6):1895-902

Schultz GA; Edwards DR, 1997. Biology and genetics of implantation.  Dev Genet 21(1):1-5

Leco KJ; Apte SS; Taniguchi GT; Hawkes SP; Khokha R; Schultz GA; Edwards DR, 1997. Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues.  FEBS Lett 401(2-3):213-7

Clark AW; Krekoski CA; Bou SS; Chapman KR; Edwards DR, 1997. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia.  Neurosci Lett 238(1-2):53-6

Edwards DR; Leco KJ; Beaudry PP; Atadja PW; Veillette C; Riabowol KT, 1996. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts.  Exp Gerontol 31(1-2):207-23

Edwards DR; Beaudry PP; Laing TD; Kowal V; Leco KJ; Leco PA; Lim MS, 1996. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth.  Int J Obes Relat Metab Disord 20 Suppl 3:S9-15

Leco KJ; Edwards DR; Schultz GA, 1996. Tissue inhibitor of metalloproteinases-3 is the major metalloproteinase inhibitor in the decidualizing murine uterus.  Mol Reprod Dev 45(4):458-65

Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR, 1996. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.  Br J Cancer 73(11):1401-8

Wallace CJ; Forsyth PA; Edwards DR, 1996. Lymph node metastases from glioblastoma multiforme.  AJNR Am J Neuroradiol 17(10):1929-31

Harvey MB; Leco KJ; Arcellana-Panlilio MY; Zhang X; Edwards DR; Schultz GA, 1995. Roles of growth factors during peri-implantation development.  Hum Reprod 10(3):712-8

Harvey MB; Leco KJ; Arcellana-Panlilio MY; Zhang X; Edwards DR; Schultz GA, 1995. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor.  Development 121(4):1005-14

Rutka J; Matsuzawa K; Hubbard S; Fukuyama K; Becker L; Stetlerstevenson W; Edwards D; Dirks P, 1995. Expression of timp-1, timp-2, 72-kda and 92-kda type-iv collagenase transcripts in human astrocytoma cell-lines - correlation with astrocytoma cell invasiveness.  Int J Oncol 6(4):877-84

Leco KJ; Khokha R; Pavloff N; Hawkes SP; Edwards DR, 1994. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues.  J Biol Chem 269(12):9352-60

Edwards DR, 1994. Cell signalling and the control of gene transcription.  Trends Pharmacol Sci 15(7):239-44

Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR, 1993. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.  Oncol Res 5(1):19-28

Urbanski SJ; Edwards DR; Hershfield N; Huchcroft SA; Shaffer E; Sutherland L; Kossakowska AE, 1993. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.  Diagn Mol Pathol 2(2):81-9

Edwards DR; Heath JK; Hogan BL; Nomura S; Wills AJ, 1992. Expression of TIMP in fetal and adult mouse tissues studied by in situ hybridization.  Matrix Suppl 1:286-93

Kossakowska AE; Urbanski SJ; Huchcroft SA; Edwards DR, 1992. Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs.  Oncol Res 4(6):233-40

Edwards DR; Mahadevan LC, 1992. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors.  EMBO J 11(7):2415-24

Urbanski SJ; Edwards DR; Maitland A; Leco KJ; Watson A; Kossakowska AE, 1992. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.  Br J Cancer 66(6):1188-94

Leco KJ; Hayden LJ; Sharma RR; Rocheleau H; Greenberg AH; Edwards DR, 1992. Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts.  Gene 117(2):209-17

Edwards DR; Rocheleau H; Sharma RR; Wills AJ; Cowie A; Hassell JA; Heath JK, 1992. Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription.  Biochim Biophys Acta 1171(1):41-55

Kossakowska AE; Urbanski SJ; Edwards DR, 1991. Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas.  Blood 77(11):2475-81

Publication list retrieved from NCBI using ImpactPubs

.